Regis Healthcare stock weighs FY26 growth against funding pressure

Published on 10/07/2026 at 00:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Regis Healthcare stock was last at AUD 4.33 on October 6, 2026, after FY26 revenue rose 16 percent. Statutory net profit reached AUD 55.7 million, while funding rose 2.55 percent.

Regis Healthcare, AU000000REG6, Illustration mit AI erstellt.

Regis Healthcare stock (ISIN AU000000REG6) was last at AUD 4.33 on the ASX on October 6, 2026 at 4:10 p.m. AEDT, down 0.69 percent from the prior close. The latest company picture combines 16 percent FY26 service revenue growth with continuing pressure from aged care funding and labor costs.

FY26 revenue reached AUD 1.35 billion

According to Motley Fool on September 14, 2026, Regis reported FY26 service revenue of AUD 1.35 billion, up 16 percent from the prior year. Statutory net profit rose 14 percent to AUD 55.7 million, while total FY26 dividends increased 13 percent to 18.4 cents per share.

The operating details add weight to that comparison. Veye reported that average occupancy reached 96 percent in FY26, while occupied bed days rose 8 percent to 2.85 million. Underlying operating profit increased 10 percent to AUD 138 million, and underlying net profit reached AUD 55.6 million, up 4 percent.

Funding growth trails cost pressure

The counterweight is the funding formula. Motley Fool reported that the AN-ACC starting price rose 2.55 percent to AUD 303.19 from October 1, 2026. Regis described the increase as below prevailing cost inflation, making occupancy, room pricing and operating efficiency important drivers for the next financial year.

Veye also reported that aged care revenue per occupied bed rose 6.7 percent in FY26, while staff expenses per occupied bed increased 8.3 percent. That gap leaves margin expansion dependent on pricing and productivity rather than funding growth alone.

Analyst target remains above AUD 4.33

Consensus data compiled by Fintel on September 15, 2026 put the average one-year price target at AUD 6.20, down 18.37 percent from AUD 7.59 on August 25. Individual targets ranged from AUD 5.05 to AUD 7.77, while the median target stood at AUD 6.09 on September 11.

That target spread frames the investment debate: the market price reflects the funding and labor-cost concern, while the consensus valuation still assigns value to the earnings recovery shown in FY26. For investors, the next test is whether occupancy and pricing gains can outpace cost growth.

Regis Healthcare stock stays below its yearly high

Regis Healthcare stock was last at AUD 4.33 on the ASX on October 6, 2026 at 4:10 p.m. AEDT. Its 52-week range was AUD 3.85 to AUD 8.20, leaving the share closer to the yearly low than the yearly high.